KARLA YANES: Open Payments
NPI 1659072213 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 63 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,245 · 2025 $1,686
Food & beverage: $1,580Education: $107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $505 |
| Regeneron Healthcare Solutions, Inc. | 9 | $199 |
| PFIZER INC. | 10 | $173 |
| GENZYME CORPORATION | 7 | $166 |
| UCB, Inc. | 5 | $159 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| E.R. Squibb & Sons, L.L.C. | 2 | $118 |
| Organon LLC | 3 | $49 |
| Incyte Corporation | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, DAXXIFY, CIBINQO, RINVOQ, Sotyktu, OPZELURA.
Industry payments across IN — which companies pay providers there.
